Anticoagulation Versus Antiplatelets in Spontaneous Cervical Artery Dissection: A Systematic Review and Meta-Analysis
Shadi YaghiLiqi ShuLauren FletcherFayez H. FayadAsghar ShahAna HerningNoail IshoPerla MansourKareem JoudiBashar ZaidatNoor A. MahmoudFeras Abdul KhalekHan XiaoEric GoldsteinMalik GhannamJames E. SieglerSetareh Salehi OmranEkaterina BakradzeThanh N. NguyenZafer KeserMuhib KhanReza Bavarsad ShahripourAdam de HavenonNils HenningerMirjam R. HeldnerThalia S. FieldYasmin AzizEva A. MistryKaren FurieStefan EngelterHugh S. MarkusDepartment of Neurology,Providence,RI. (S.Y.,L.S.,F.H.F.,A.S.,K.J.,E.G.,K.F.)Brown University Library,Health and Biomedical Library Services,Providence,RI. (L.F.)Boston University Medical School,MA (A.H.).University of Washington Medical School,Seattle (N.I.).American University of Beirut Medical School,Lebanon (P.M.).Mount Saini School of Medicine,New York (B.Z.).Department of Neurology,University of Oklahoma,Norman (N.A.M.).Department of Hematology and Oncology,Luminis Health,Annapolis,MD (F.A.K.).Department of Economics,University of California Santa Barbara (H.X.).Department of Neurology,University of Iowa,Iowa City (M.G.).Department of Neurology,University of Chicago,IL (J.E.S.).Department of Neurology,University of Colorado,Aurora (S.S.O.).Department of Neurology,University of Alabama at Birmingham (E.B.).Department of Neurology,Boston University,MA (T.N.N.).Department of Neurology,Mayo Clinic,Rochester,MN (Z.K.,M.K.).Department of Neurology,University of California San Diego (R.B.S.).Department of Neurology,Yale New Haven Hospital,CT (A.d.H.).Department of Neurology,University of Massachusetts,Chan Medical School,Worcester (N.H.).Department of Neurology,Inselspital,University Hospital and University of Bern,Switzerland (M.R.H.).Division of Neurology,University of British Columbia,Vancouver,CA (T.S.F.).Department of Neurology,University of Cincinnati,OH (Y.A.,E.A.M.).Neurology and Neurorehabilitation,University Department of Geriatric Medicine FELIX PLATTER,University of Basel,Department of Neurology and Stroke Center,and University Hospital Basel,Department of Clinical Research,Switzerland (S.E.).Department of Clinical Neurosciences,University of Cambridge,United Kingdom (H.S.M.).
DOI: https://doi.org/10.1161/strokeaha.124.047310
IF: 10.17
2024-06-08
Stroke
Abstract:Stroke, Ahead of Print. BACKGROUND:It is uncertain whether antiplatelets or anticoagulants are more effective in preventing early recurrent stroke in patients with cervical artery dissection. Following the publication of the observational Antithrombotic for STOP-CAD (Stroke Prevention in Cervical Artery Dissection) study, which has more than doubled available data, we performed an updated systematic review and meta-analysis comparing antiplatelets versus anticoagulation in cervical artery dissection.METHODS:The systematic review was registered in PROSPERO (CRD42023468063). We searched 5 databases using a combination of keywords that encompass different antiplatelets and anticoagulants, as well as cervical artery dissection. We included relevant randomized trials and included observational studies of dissection unrelated to major trauma. Where studies were sufficiently similar, we performed meta-analyses for efficacy (ischemic stroke) and safety (major hemorrhage, symptomatic intracranial hemorrhage, and death) outcomes using relative risks.RESULTS:We identified 11 studies (2 randomized trials and 9 observational studies) that met the inclusion criteria. These included 5039 patients (30% [1512] treated with anticoagulation and 70% [3527]) treated with antiplatelets]. In meta-analysis, anticoagulation was associated with a lower ischemic stroke risk (relative risk, 0.63 [95% CI, 0.43 to 0.94];P=0.02; I2=0%) but higher major bleeding risk (relative risk, 2.25 [95% CI, 1.07 to 4.72];P=0.03, I2=0%). The risks of death and symptomatic intracranial hemorrhage were similar between the 2 treatments. Effect sizes were larger in randomized trials. There are insufficient data on the efficacy and safety of dual antiplatelet therapy or direct oral anticoagulants.CONCLUSIONS:In this study of patients with cervical artery dissection, anticoagulation was superior to antiplatelet therapy in reducing ischemic stroke but carried a higher major bleeding risk. This argues for an individualized therapeutic approach incorporating the net clinical benefit of ischemic stroke reduction and bleeding risks. Large randomized clinical trials are required to clarify optimal antithrombotic strategies for management of cervical artery dissection.
peripheral vascular disease,clinical neurology